(Q39819996)

14 September 2017

1 reference

title

Anticancer drug pharmacodynamics (English)

1 reference

14 September 2017

G Powis

1

1 reference

14 September 2017

1 January 1985

1 reference

Cancer Chemotherapy and Pharmacology

14 September 2017

1 reference

14 September 2017

14

1 reference

14 September 2017

177-183

1 reference

14 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00258112

14 September 2017

0 references

cites work

Combination clinical trials with thymidine and fluorouracil: a phase I and clinical pharmacologic evaluation

1 reference

12 December 2020

Clinical effects and pharmacokinetics of different dosage schedules of adriamycin

1 reference

12 December 2020

Combinations of tetrahydrouridine and cytosine arabinoside in mouse tumors

1 reference

12 December 2020

Clinical pharmacology of bruceantin by radioimmunoassay

1 reference

12 December 2020

Phase I study of cis-diamminedichloroplatinum(II) administered as a constant 5-day infusion

1 reference

12 December 2020

Plasma half-life of cytosine arabinoside (NSC-63878) in patients treated for acute myeloblastic leukemia

1 reference

12 December 2020

Increasing therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology

1 reference

12 December 2020

Pharmacodynamics of Chemotherapeutic Effects: Dose-Time-Response Relationships for Phase-Nonspecific Agents

1 reference

12 December 2020

Acute doxorubicin toxicity. Relationship to pretreatment liver function, response, and pharmacokinetics in patients with acute nonlymphocytic leukemia

1 reference

12 December 2020

The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukaemia

1 reference

12 December 2020

Plasma concentrations of carminomycin and carminomycinol in man, measured by high pressure liquid chromatography

1 reference

12 December 2020

In vitro assays in preclinical antineoplastic drug screening.

1 reference

12 December 2020

Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia

1 reference

12 December 2020

Parenteral formulation of hexamethylmelamine potentially suitable for use in man

1 reference

12 December 2020

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer

1 reference

12 December 2020

Chloroethylnitrosourea cancer chemotherapeutic agents

1 reference

12 December 2020

Pharmacokinetics and metabolism of adriamycin in man

1 reference

12 December 2020

Comparative Drug Metabolism

1 reference

12 December 2020

Variable oral absorption of hexamethylmelamine in man

1 reference

12 December 2020

Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity

1 reference

12 December 2020

A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.

1 reference

12 December 2020

Concentration and time-dependent inter-relationships for antitumour drug cytotoxicities against tumour cells in vitro

1 reference

12 December 2020

Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells

1 reference

12 December 2020

Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity

1 reference

12 December 2020

Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion

1 reference

12 December 2020

Clinical pharmacokinetics of vinblastine by continuous intravenous infusion

1 reference

12 December 2020

Plasma adriamycin and daunorubicin levels by fluorescence and radioimmunoassay

1 reference

12 December 2020

Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications

1 reference

12 December 2020

Pharmacokinetic considerations in the design of optimal chemotherapeutic regimens for the treatment of breast carcinoma: a comceptual approach

1 reference

12 December 2020

Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells

1 reference

12 December 2020

High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvement

1 reference

12 December 2020

The effects of chemotherapy on the kinetics of leukemic cell behavior

1 reference

12 December 2020

Pharmacokinetic studies of anticancer drugs in tumor-bearing animals.

1 reference

12 December 2020

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

1 reference

12 December 2020

Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion pattern

1 reference

12 December 2020

Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas

1 reference

12 December 2020

Pharmacodynamic and pharmacokinetic measurements of antitumor agents

1 reference

12 December 2020

Plasma half-life of cytosine arabinoside in patients with leukaemia--the effect of uridine

1 reference

12 December 2020

A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. II. Alterations in the kinetics of covalent binding.

1 reference

12 December 2020

Dose: a critical factor in cancer chemotherapy

1 reference

12 December 2020

Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

1 reference

12 December 2020

Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity

1 reference

12 December 2020

Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease

1 reference

12 December 2020

Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma

1 reference

12 December 2020

Can severe vincristine neurotoxicity be prevented?

1 reference

12 December 2020

Renal toxicity studies of protein-bound platinum(cis)

1 reference

12 December 2020

Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia

1 reference

12 December 2020

Dose-Dependent Metabolism, Therapeutic Effect, and Toxicity of Anticancer Drugs in Man

1 reference

12 December 2020

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

1 reference

12 December 2020

Human pharmacokinetics of a new acridine derivative, 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992)

1 reference

12 December 2020

Determination of 5-fluorouracil in plasma by GC/MS using an internal standard. Applications to pharmacokinetics

1 reference

12 December 2020

Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics.

1 reference

12 December 2020

The clinical pharmacology of methotrexate.new applications of an old drug

1 reference

12 December 2020

Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00258112

1 reference

release_2ti4fk5no5efnkabdy7x7ukdhe

14 September 2017

0 references

PubMed ID

3888428

1 reference

PubMed ID

3888428